Citation Impact
Citing Papers
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
2006 Standout
Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c- MYC transcription
2002 Standout
Computational Thermostabilization of an Enzyme
2005 StandoutScienceNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
1999
Untangling the ErbB signalling network
2001 Standout
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
1993 StandoutNature
Structure and function of cellular deoxyribonucleoside kinases
2002
The Hepatitis B Virus-Trimera Mouse: A Model for Human Hbv Infection and Evaluation of Anti–Hbv Therapeutic Agents
1999
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Enzyme-Catalyzed Activation of Anticancer Prodrugs
2004
Crystal Structure of a pol α Family Replication DNA Polymerase from Bacteriophage RB69
1997 StandoutNobel
Hepatitis B: Reflections on the current approach to antiviral therapy
2008
Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval
2000 StandoutNature
Clinical Pharmacokinetics of Topotecan
1996
Progress in Antisense Oligonucleotide Therapeutics
1996
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
1996 Standout
Synthesis and Properties of Allenic Natural Products and Pharmaceuticals
2004 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
CpG motifs in bacterial DNA trigger direct B-cell activation
1995 StandoutNature
Hepatitis B virus infection
2009 Standout
The development of androgen-independent prostate cancer
2001 Standout
An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3′ mispaired DNA
2002 Nature
Phosphorothioate analogs of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates
1987 StandoutNobel
Exploiting tumour hypoxia in cancer treatment
2004 Standout
The Exonuclease Activity of Human Apurinic/Apyrimidinic Endonuclease (APE1)
2003
Cancer genes and the pathways they control
2004 Standout
Postsynaptic Induction and PKA-Dependent Expression of LTP in the Lateral Amygdala
1998 StandoutNobel
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
2001
Inhibition of Epstein-Barr virus replication by a novel l-nucleoside, 2′-fluoro-5-methyl-β-l-arabinofuranosyluracil
1996
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
1993 Science
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Structure of Taq polymerase with DNA at the polymerase active site
1996 StandoutNatureNobel
Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR)
1999 StandoutNobel
Chronic Myelogenous Leukemia
2002
Enantioselectivity of the antiviral effects of nucleoside analogues
2000
Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties
1990
Neuroblastoma
2007 Standout
Topoisomerase I inhibitors: Review and update
1997
Oncogenic DNA viruses
2001 StandoutNobel
A Novel Action of Human Apurinic/Apyrimidinic Endonuclease
2000
Gold Nanoparticles for Biology and Medicine
2010 Standout
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Gene inhibition using antisense oligodeoxynucleotides
1994 Nature
Suppression of Human Immunodeficiency Virus Type 1 Activity in Vitro by Oligonucleotides Which Form Intramolecular Tetrads
1995
Comparison of Cellular Binding and Uptake of Antisense Phosphodiester, Phosphorothioate, and Mixed Phosphorothioate and Methylphosphonate Oligonucleotides
1993
Replication of hepatitis C virus
2007 StandoutNobel
Human cytomegalovirus induces JC virus DNA replication in human fibroblasts.
1993
Molecular Targets for AIDS Therapy
1990 Science
cAMP Response Element-Binding Protein in the Amygdala Is Required for Long- but not Short-Term Conditioned Taste Aversion Memory
1997
Antiviral therapy for human immunodeficiency virus infections
1995
Advanced Glycation End Products
2006 Standout
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
Molecular Modeling Studies of the DNA−Topoisomerase I Ternary Cleavable Complex with Camptothecin
1998 StandoutNobel
Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay.
1995
Antisense to LOX-1 Inhibits Oxidized LDL–Mediated Upregulation of Monocyte Chemoattractant Protein-1 and Monocyte Adhesion to Human Coronary Artery Endothelial Cells
2000 Standout
Kinetic and Mechanistic Analysis of Nonenzymatic, Template-Directed Oligoribonucleotide Ligation
1996 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome
1989 StandoutNobel
Antisense Oligonucleotides: Promise and Reality
2001
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
UO‐Catalyzed Oligothioadenylate Synthesis with High Regio‐ and Stereoselectivity
1993
Dendrimers—Branching out from curiosities into new technologies
1998 StandoutNobel
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Plant Products as Antimicrobial Agents
1999 Standout
New Unnatural L-Nucleoside Enantiomers:From Their Stereospecific Synthesis to Their Biological Activities
1997
Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma
2001
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus
1995
A Field Guide to Foldamers
2001 Standout
Expression of herpes simplex virus type 1 DNA polymerase gene by in vitro translation and effects of gene deletions on activity
1988
Synthesis of 2′-O,4′-C-methyleneuridine and -cytidine. Novel bicyclic nucleosides having a fixed C3, -endo sugar puckering
1997
The Chemistry of Neutron Capture Therapy
1998 Standout
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
Sequence and mapping analyses of the herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain.
1985
Cyclophosphamide Plus Topotecan in Children With Recurrent or Refractory Solid Tumors: A Pediatric Oncology Group Phase II Study
2001
A single residue in DNA polymerases of the Escherichia coli DNA polymerase I family is critical for distinguishing between deoxy- and dideoxyribonucleotides.
1995
Efficient and Rapid Template-Directed Nucleic Acid Copying Using 2′-Amino-2′,3′-dideoxyribonucleoside−5′-Phosphorimidazolide Monomers
2009 StandoutNobel
Interaction of DNA polymerase and nucleotide analog triphosphates
1985
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE
1997
The scanning model for translation: an update.
1989 Standout
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
2012
Introduction of [2]Catenanes into Langmuir Films and Langmuir−Blodgett Multilayers. A Possible Strategy for Molecular Information Storage Materials
1999 StandoutNobel
Both Protein Kinase A and Mitogen-Activated Protein Kinase Are Required in the Amygdala for the Macromolecular Synthesis-Dependent Late Phase of Long-Term Potentiation
2000 StandoutNobel
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
Na+/Ca2+exchange in neonatal rat heart cells: antisense inhibition and protein half-life
1998
Works of Yi-Ting Cheng being referenced
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.
1994
Dose-escalation and pharmacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer.
1997
Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogs, and crystal structure of 1-(3-deoxy-.beta.-D-threo-pentofuranosyl)cytosine
1991
Effect of Phosphorothioate Homo-oligodeoxy nucleotides on Herpes Simplex Virus Type 2-induced DNA Polymerase
1989
An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116.
1994
2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo
1996
Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification
1993
Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
1982
Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
1992
Human cytomegalovirus-induced DNA polymerase and its interaction with the triphosphates of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil, -5-iodocytosine, and -5-methylcytosine
1985
Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.
1995